UC 8024 PHARM EXAM 4 QUESTION AND

Study Guides Aug 14, 2025
Loading...

Loading document viewer...

Page 0 of 0

Document Text

  • | Page

UC 8024 PHARM EXAM 4 QUESTION AND

ANSWERS CORRECTLY SO LVED

Question : Biguanides (Metformin)

Correct answer: First line agent for DMII

MOA: Decreases liver glucose production

ADE: diarrhea and abdominal pain

BBW: Lactic Acidosis - rare

Contra: Pts with renal impairment

Question : Sulfonylureas

Correct answer: MOA: Increased endogenous insulin secretion (binding to pancreatic beta receptors to trigger insulin release)

ADE: Hypoglycemia (combined w/ other agents), wt gain, rash

(sulfa), HA, N/V, photosensitivity

Caution: Renal/hepatic impairment

  • | Page

Question : Thiazolidinediones (TZDs)

Correct answer: MOA: Increases muscle and adipose cell sensitivity to insulin & suppresses liver glucose production

ADE: Wt gain, edema, hypoglycemia (if taken w/ insulin),

possible increased fracture risk (women),

BBW: CHF

Caution: hepatic impairment

Question : Meglitinides

Correct answer: MOA: stimulate insulin secretion in presence of glucose

ADE: Hypoglycemia (if patient has abnormal eating schedule),

wt gain, SJS,

Contra: with use of gemfibrozil

  • | Page

Caution: hepatic dysfunction

Medications in class: Repaglinide (Prandin), Nateglinide

(Starlix)

Question : GLP-1 Agonists

Correct answer: MOA: increases glucose-mediated insulin release. suppresses glucagon secretion, delays gastric emptying

ADE: wt. loss, GI symptoms, pancreatitis

Caution: renal dysfunction, severe gastroparesis

Medications in class: exenatide (Byetta), liraglutide (Victoza,

Dulaglutide (Trulicity)

Question : SGLT2 Inhibitors

Correct answer: MOA: Block renal glucose resorption - causes glucosuria

ADE: GU infections, Wt loss, polyuria, dehydration

  • | Page

Contra: severe renal impairment

**Fracture risk ***Dose-related increase in LDL

Question : Alpha-glucosidase Inhibitors

Correct answer: MOA: blocks enzymes that digest starch in small bowel; causing decreased glucose absorption

ADE: flatulence, abdominal discomfort

Hypoglycemia risk with secretagogue

Contra: pts with IBS or cirrhosis

Medications in this class: acarbose (Precose) and miglitol

(Glyset)

Question : DPP-4 Inhibitor

Download Document

Buy This Document

$30.00 One-time purchase
Buy Now
  • Full access to this document
  • Download anytime
  • No expiration

Document Information

Category: Study Guides
Added: Aug 14, 2025
Description:

UC 8024 PHARM EXAM 4 QUESTION AND ANSWERS CORRECTLY SO LVED Question : Biguanides (Metformin) Correct answer: First line agent for DMII MOA: Decreases liver glucose production ADE: diarrhea and abd...

Get this document $30.00